This site is intended for healthcare professionals only
LoginRegister
Granules Secures Sole First-to-File Status for Generic Narcolepsy Drug LUMRYZ in USGranules Secures Sole First-to-File Status for Generic Narcolepsy Drug LUMRYZ in US
Himachal HC Quashes CDSCO Prosecution Against Pharma Firms Over NSQ DrugsHimachal HC Quashes CDSCO Prosecution Against Pharma Firms Over NSQ Drugs
NPPA Expert Committee Seeks More Evidence on Povidone Iodine Throat Sprays Indigenous DevelopmentNPPA Expert Committee Seeks More Evidence on Povidone Iodine Throat Spray's Indigenous Development
Glenmark Launches Generic Olanzapine Injection in US, Targets USD 25.4 Million MarketGlenmark Launches Generic Olanzapine Injection in US, Targets USD 25.4 Million Market
Lupin Among 16 Indian Firms Featured in TIMEs Sustainability RankingsLupin Among 16 Indian Firms Featured in TIME's Sustainability Rankings
USFDA Warns Hyderabad Firm Over Sale of Unapproved Ayurvedic Sexual Wellness ProductsUSFDA Warns Hyderabad Firm Over Sale of Unapproved Ayurvedic Sexual Wellness Products
NPPA Slaps GSK Pharma with Rs 3.54 Crore Demand Over Alleged Drug OverchargingNPPA Slaps GSK Pharma with Rs 3.54 Crore Demand Over Alleged Drug Overcharging
UPSC Invites Pharmacy, Medical Graduates for 186 CDSCO Drug Inspector PostsUPSC Invites Pharmacy, Medical Graduates for 186 CDSCO Drug Inspector Posts
USFDA Clears AbbVies Pivekimab for Rare Blood Cancer TreatmentCDSCO Panel Rejects AbbVie's Clinical Trial Waiver Plea for Foslevodopa-Foscarbidopa Injection
Emcure Unit Marcan to Acquire Remaining Stake in Canadas Mantra Pharma for CAD 50 MillionEmcure Unit Marcan to Acquire Remaining Stake in Canada's Mantra Pharma for CAD 50 Million
CDSCO Restricts Supply of IVF Media, Consumables to Registered ART Centres OnlyCDSCO Restricts Supply of IVF Media, Consumables to Registered ART Centres Only
Alkem Labs Gets Appellate Relief in Rs 660.77 Crore Income Tax DisputeAlkem Labs Gets Appellate Relief in Rs 660.77 Crore Income Tax Dispute
X